Afuco™ Anti-FGF23 ADCC Recombinant Antibody (Burosumab), ADCC Enhanced (CAT#: AFC-TAB-010ML)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to FGF23. Burosumab is a human monoclonal antibody that can be potentially used in the treatment of Dermatological genetic disorders, Hypophosphatemia, Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS), X-linked (Hereditary hypophosphatemic rickets), Osteomalacia, oncogenic.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Specificity
  • Human FGF23
  • Species Reactivity
  • Human
  • Clone
  • Burosumab
  • Applications
  • ELISA, IHC, FC, IP, IF, Inhib
  • Conjugate
  • Unconjugated
  • Generic Name
  • Burosumab
  • Related Disease
  • Dermatological genetic disorders, Hypophosphatemia, Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS), X-linked (Hereditary hypophosphatemic rickets), Osteomalacia, oncogenic

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Fibroblast growth factor 23

Related Resources

  • Biosimilar Overview
Please refer to Burosumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Burosumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Burosumab"

Anti-Human FGF23 Recombinant Antibody (Burosumab)
Recombinant monoclonal antibody to FGF23. Burosumab is a human monoclonal antibody that can be potentially used in the treatment of Dermatological genetic disorders, Hypophosphatemia, Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS), X-linked (Hereditary hypophosphatemic rickets), Osteomalacia, oncogenic.

See other products for "FGF23"

Recombinant Antibody

Human Antibody

CAT Product Name Application Type
TAB-010ML Anti-Human FGF23 Recombinant Antibody (Burosumab) ELISA, IHC, FC, IP, IF, Inhib IgG1, κ

scFv Fragment Antibody

CAT Product Name Application Type
HPAB-0207-YC-S(P) Human Anti-FGF23 Recombinant Antibody; scFv Fragment (HPAB-0207-YC-S(P)) ELISA, FuncS Human scFv

Fab Fragment Antibody

CAT Product Name Application Type
HPAB-0207-YC-F(E) Human Anti-FGF23 Recombinant Antibody; Fab Fragment (HPAB-0207-YC-F(E)) ELISA, FuncS Human Fab

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-010ML. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare